Effects of Low Concentration of Selected Analgesics and Successive Bioaugmentation of the Activated Sludge on Its Activity and Metabolic Diversity

• Main Authors: Joanna Żur, Justyna Michalska, Artur Piński, Agnieszka Mrozik, Agnieszka Nowak
• Format: Article
• Language: English
• Published: MDPI AG 2020-04-01
• Series: Water
• Subjects: activated sludge; bacterial consortium; bioaugmentation; biodegradation; functional capacity; non-steroidal anti-inflammatory drugs (NSAIDs)
• Online Access: https://www.mdpi.com/2073-4441/12/4/1133

In this study, we evaluated the impact of the successive bioaugmentation of the activated sludge (AS) with the defined bacterial consortium on the activity and functional capacity of the AS microorganisms. In parallel, the removal of low concentrations of the selected non-steroidal anti-inflammatory drugs (ibuprofen, naproxen, diclofenac) and analgesic paracetamol was studied. We found that the addition of the bacterial consortium consisting of three pharmaceuticals-degrading strains <i>Bacillus thuringiensis</i> B1 (2015b), <i>Stenotrophomonas maltophilia</i> KB2, and <i>Pseudomonas moorei</i> KB4 into the AS did not cause any significant changes in the biomass abundance and metabolic activity of the AS microorganisms. Although, the successive bioaugmentation of the AS caused a slight increase in the metabolic diversity, the intensity of carbohydrates usage, and metabolic richness. Microorganisms in the bioaugmented and non-bioaugmented AS were able to degrade the mixture of the analyzed drugs with similar efficiency, however, diclofenac was removed more effectively in the bioaugmented AS. Several metabolites were identified and efficiently utilized, with the exception of 4-OH diclofenac. Two new diclofenac-degrading strains assigned as <i>Serratia proteamaculans</i> AS4 and <i>Rahnella bruchi</i> AS7 were isolated from the diclofenac-treated AS.